✦ LIBER ✦
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 µg QOD in patients with relapsing-remitting multiple sclerosis: A multicenter, randomized, double-blind, parallel-group pilot study
✍ Scribed by Barrie J. Hurwitz; Douglas Jeffery; Barry Arnason; Kim Bigley; Patricia Coyle; Douglas Goodin; Samer Kaba; Stephen Kirzinger; Sharon Lynch; Raul Mandler; Daniel Mikol; Kottil Rammohan; Richard Sater; Subramaniam Sriram; Ben Thrower; Francis Boateng; Peter Jakobs; Mary Beth Wash; Timon Bogumil
- Book ID
- 116372191
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 213 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0149-2918
No coin nor oath required. For personal study only.